iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) — ETF Analysis on Winston

Key Facts

• Issuer: IShares
• Category: Equity
• Asset Class: Equity
• Price: $8.38
• Expense Ratio: 35.00%
• Assets Under Management: $959M
• Number of Holdings: 255
• Inception Date: 2017-10-19
• Currency: EUR

Winston Score

iShares Nasdaq US Biotechnology UCITS ETF has a Winston Score of 72 out of 100.

Performance

• 1-Year Return: 37.85%
• 3-Year Return: 35.56%
• 5-Year Return: 24.28%

Top Holdings

AMGEN INC (N/A%), VERTEX PHARMACEUTICALS INC (N/A%), GILEAD SCIENCES INC (N/A%), REGENERON PHARMACEUTICALS INC (N/A%), ALNYLAM PHARMACEUTICALS INC (N/A%)

Sector Breakdown

Healthcare (N/A%)